It would therefore be compelling to continue to clinically study the association between this marker and survival rates in neuroblastoma and identify related genes that may aid in the establishment of a prognostic gene panel or combine it with well-established prognostic genes such as ALK, PHOX2B, and PTPRD [43]. The gene discussed is ALK; the disease is neuroblastoma.